|
|
 |
SALONPAS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SPINRAZA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SCENESSE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SAVAYSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|